| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $321K | -57.1% |
| Cost of Revenue | $228K | -72.5% |
| Gross Profit | $93K | +211.2% |
| R&D Expense | $2.1M | +37.3% |
| SG&A Expense | $2.7M | +36.6% |
| Operating Income | -$4.8M | -35.4% |
| Interest Expense | $52K | +219.0% |
| Net Income | -$5.7M | -81.2% |
| EPS (Basic) | -$0.45 | -80.0% |
| EPS (Diluted) | -$0.31 | -24.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | -7.7% |
| Accounts Receivable | $51K | +722.5% |
| Current Assets | $2.5M | -10.2% |
| Total Assets | $4.2M | +10.0% |
| Current Liabilities | $507K | +118.6% |
| Long-term Debt | $265K | -23.4% |
| Total Liabilities | $5.7M | +895.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.4M | -37.5% |
| Capital Expenditures | $310K | +854.4% |
| Investing Cash Flow | -$310K | -854.4% |
| Financing Cash Flow | $3.5M | -26.9% |
| Free Cash Flow | -$3.7M | -48.1% |
| Stockholders' Equity |
| -$1.6M |
| -148.9% |